Skip to main content

MMGUI60 Managing & Supporting Staff - Med Error v6

Page 1

MMGUI60

Guidelines for Managing and Supporting Staff following a Medication Error

Page 1 of 16


Version:

V6

Ratified by:

Medicines Governance and Safety Group

Date ratified:

06/08/2026

Job Title of author:

Head of Medicines Management

Reviewed by Committee or Expert Group

Medicines Governance and Safety Group

Related procedural documents

MMPOL30 Medicines Policy MMSOP34 Management of Pharmaceutical Waste in Community Hospitals and Community Clinics MMSOP41 Controlled Drugs Suite of SOPs MMPOL31 Controlled Drugs Policy MMSOP63 Safe use of Gabapentin and Pregabalin in Community Inpatient/service user/customer Wards HRPOL26 Psychological Wellbeing of Staff Policy QSPOL01 All Incident Reporting (including Serious Incident Reporting) & Management Policy HRPOL14 Disciplinary Policy and Procedure QSPOL03 Being Open and Duty of Candour Policy MMPOL36 Management of Medicines in Provide Care Solutions and REACT (Domiciliary Care and Supported Living services) MMPOL37 Management of Medicines in Provide Care Solutions Care Homes MMSOP68 Suite of Standard Operating Procedures (SOPs) for the Management of Medicines in Care Homes (Fern Lodge) 06/08/2029

Review date:

It is the responsibility of users to ensure that you are using the most up to date document template – ie obtained via the intranet. In developing/reviewing these guidelines Provide Community has had regard to the principles of the NHS Constitution.

Page 2 of 16


Version Control Sheet Version V1

Date August 2014

Author Head of Medicines Management

Status Approved

V2

November 2016

Head of Medicines Management

Review

V3

March 2019

Head of Medicines Management

Review

V4

August 2019

Community Health Specialist Pharmacist

Update

May 2023

Clinical Lead Pharmacist Head of Pharmacy

Review

V5 V6

August 2026

Head of Quality and Safety

Page 3 of 16

Update

Comment New

Alignment to QSPOL01 Incident Reporting and Management Policy V2 (ratified 31 March 2026)


Contents 1.

Introduction .......................................................................................................... 5

2.

Purpose ............................................................................................................... 5

3.

Definitions ............................................................................................................ 5

4.

Scope .................................................................................................................. 6

5.

Process to Follow ................................................................................................ 6

6.

Medication Errors/Near Misses ............................................................................ 9

7.

Role of the Pharmacy Team ................................................................................ 9

8.

Training and Competencies .............................................................................. 10

Appendix 1: Algorithm for the Management of Medication Errors/Near Misses .......... 11 Appendix 2: Managing a Medication Error/Near Miss – Things to Consider ............... 12 Appendix 3: Clinical Incidents Related to Medicines ................................................. 13 Appendix 4: Stages of Medication Processes ........................................................... 15 Appendix 5: Being Fair Tool ...................................................................................... 16

Page 4 of 16


1. Introduction Provide recognises the importance of supporting staff when they have been involved in a medication error or a near miss. Such an event can present stress and concern for health practitioners and especially where there is a direct impact on a patient/service user/customer. Provide approach to medication incidents is aligned to the Incident Reporting and Management Policy (QSPOL01) and the NHS Patient Safety Incident Response Framework (PSIRF). This approach promotes a culture that supports openness, learning and compassionate engagement with patient/service user/customers, carers and colleagues when things go wrong. Medication incidents, including near misses, are recognised as opportunities to improve systems and reduce future harm. Staff are encouraged and expected to report incidents without fear of blame, and to be supported throughout the incident response and learning process.

2. Purpose This guidance aims to standardise the management of medication errors or near misses across Provide Group. It also aims to ensure that staff involved in medication incidents are supported emotionally, professionally and organisationally, recognising the potential impact of incidents on individual wellbeing (“second victims”). This guidance: • Encourages timely reporting of medication incidents and near misses • Supports learning to improve medication safety • Ensures responses to incidents are proportionate to harm and risk, in line with PSIRF • Sets out the support requirements for staff following a medication incident, the responsibilities of managers when dealing with medicines errors or near misses • Sets out appropriate actions and support necessary for all staff when an error or near miss occurs

3. Definitions Medication Patient Safety Incident Any unintended or unexpected incident related to prescribing, dispensing, administration, monitoring, or advice on medicines that caused, or could have caused, harm.

Medication Error Medication errors are any PSIs where there has been an error in the process of prescribing, preparing, dispensing, administering, monitoring or providing advice on medicines. These PSIs can be divided into two categories; errors of commission or errors of omission. The former includes, for example, wrong medicine or wrong dose. The latter include, for example, omitted dose or a failure to monitor, such as international normalised ratio for anticoagulant therapy.

Page 5 of 16


Near Miss This is defined as an event or situation that could have resulted in harm, loss or damage but because of timely intervention, did not actually occur. Second Victim A member of staff involved in a patient safety incident who may experience emotional distress, anxiety, loss of confidence, or psychological harm as a result of the event.

4. Scope Divisional Operational Leads All divisional operational leads must be familiar with this guidance to ensure they understand how the guidance should be applied in practice.

Service Managers, Clinical Managers and Registered Managers Managers are responsible for ensuring medication incidents are managed in line with this guidance, relatable procedural documents for medicines management and incident (Social Care/PCS/REACT/Care Homes) and QSPOL01 All Incident Reporting (including Serious Incident Reporting) & Management Policy. Managers must also ensure that staff involved in medication incidents are treated with compassion and respect, are supported appropriately, and are engaged in learning processes unless there is a clear and immediate risk to patient/service user/customer safety.

Pharmacy Team In the event of a medication error or near miss, the Pharmacy Team will review medication incidents to identify themes, learning and training needs. The pharmacy team may be approached at any stage for immediate advice and support. The Medication Safety Officer (MSO) will review each reported medicine incident in a systematic way and advise on any further action required. Feedback will be provided to the relevant senior managers, as well as to the person reporting the incident, and via the Medicines Governance & Safety Group (MGSG). The MSO will provide advice to support learning and system improvement.

All Staff including bank/agency/locum/workforce solution All staff who are involved in the medication process must familiarise themselves with this guidance, so they understand their individual responsibilities and those of Provide.

5. Process to Follow Provide acknowledges that medication errors or near misses will sometimes happen. What is important is that the organisation and those staff involved in the incident have a clear understanding after the event of the following: • • • • •

If there has been any harm done to a patient/service user/customer as a consequence of the incident The causal factors that contributed to the incident Any potential actions that could have been taken to prevent it happening Any training needs arising from the incident Whether any staff involved in the current incident have been involved in more than one medication incident over a defined period of time (see Appendix 1) Page 6 of 16


• • •

If there is an immediate need to address any disciplinary issues arising from the incident If there are any Provide processes that need to be reviewed If there is any Organisational learning

Provide expects that after each reported medication error or near miss, a thorough investigation should be carried out at local level. The purpose of this investigation is to ensure the points set out above can be answered. This process should be carried out sensitively and any necessary support offered to the staff involved, in line with recommendations made by the NPSA. However, it must be noted that, where incidents are found to involve gross carelessness, repeated errors, criminal, deliberate or malicious actions, action will proceed in line with the Provide Capability or Disciplinary procedures.

Actions to be taken by a member of staff involved in a medication error or near miss As soon as the error or near miss is identified, staff should: • Assess the patient/service user/customer’s condition if appropriate, to establish if the patient/service user/customer has suffered any harm • Seek urgent clinical advice where required • Discuss and agree who will inform the patient/service user/customer/carer that a medication error has occurred • Report the incident to the Doctor responsible for the patient/service user/customer’s care • Where needed contact 111 or community pharmacy team for advice • Document the incident in the patient/service user/customer’s records • Escalate concerns to the most senior person on duty • Report the incident on Datix as soon as possible and within 24 hours of discovery, in line with QSPOL01 • If the error involved a Schedule 2 or 3 Controlled Drug (Sch 2 or 3 CD) then the Accountable Officer (AO), Nisha Desai, needs to be informed within 24 hours and a Datix raised WITHIN 48 hours. Contact Details: Nisha Desai, 07580 911601 Nisha.desai@nhs.net • • •

If required, seek further advice from a member of the Pharmacy Team If the incident involves a dispensing error, inform the relevant pharmacy immediately. The Pharmacy team should also be informed at the same time, so they can also consider the implications of the error Consider any further actions necessary following the incident (see Appendix 2)

Actions to be taken by Managers / Senior Clinicians / Registered Managers It is the responsibility of the senior clinician/manager/registered manager to whom the incident has been reported, to undertake the following actions: • Follow the ‘Algorithm for the Management of Medication Errors/Near Misses (Appendix 1) • In the first instance they must: o Confirm the status of the patient/service user/customer, if relevant, and check if any harm has occurred o Ensure that all appropriate support has been offered to the member of staff involved in the incident and their wellbeing considered Page 7 of 16


o o o •

Where appropriate contact 111 or community pharmacy for advice Confirm that the Doctor in charge of the patient/service user/customer’s care has been informed Confirm that the incident has been reported on Datix

In following the algorithm, they should ensure that: o Once the severity of risk has been confirmed, the manager should follow the steps of the algorithm set out in Appendix 1 o The incident would be reviewed and escalated in line with QSPOL01 Provide Group Incident Reporting and Management Policy o At the appropriate time, allow the member(s) of staff involved in the incident to reflect on the circumstances, and identify their own learning o Identify if there are any training or performance issues with the member(s) of staff, and depending upon the level of risk, take any necessary actions. According to the level of risk identified, this could involve re-assessment of competency or immediate suspension of the member of staff from prescribing, dispensing, preparing or administering medication

Informing the Patient/service user/customer/Carer administration error has occurred • •

•

if

a

medication

It is important for Provide to be open and honest when things go wrong, and therefore it is of great importance that a patient/service user/customer or their carers are informed if a medication error has occurred The patient/service user/customer/carer should be informed at an appropriate time by either the nurse or doctor in charge of the patient/service user/customer’s care, and an apology offered. This apology should be noted in the patient/service user/customer’s record as per the Duty of Candour processes (QSPOL03 Being Open and Duty of Candour Policy) If the error is of a serious nature, following a formal investigation and at the appropriate time, the patient/service user/customer/carer should be offered the opportunity to discuss the outcome of the investigation and to discuss the findings. This provides an opportunity to reassure the patient/service user/customer/carer that Provide is keen to always learn lessons from medication errors, and to prevent similar occurrences in the future

Supporting staff following a medication error/near miss After a medication error or near miss has occurred, and all necessary immediate steps have been taken, it is important there should be an opportunity for the staff member(s) to discuss the incidents with their manager, as soon as possible after the incident. Managers must ensure a structured, compassionate approach to supporting staff involved in medication incidents. The purpose of this discussion is to: • Provide a non-judgemental discussion • Reassure staff that reporting is expected and valued • Discuss the incident to enable the member of staff to reflect on the circumstances and identify what can be done to prevent future occurrence • Allow the member of staff to reflect and discuss how they feel and discuss any concerns they may have, assess wellbeing and ability to continue duties • Consider a hot debrief or Swarm Huddle where appropriate • Identify if there are any training or performance issues with the member of staff • Determine if the medication incident is a repeat incident; check if the member of staff has made a previous similar medication error and within what timeframe Page 8 of 16


• • •

Dependent upon the severity of the error/near miss, to ensure all appropriate support has been offered to the member of staff Determine whether the medication incident is a procedural/ system error and policies need to be reviewed accordingly If the error occurred due to a Provide process, then the organisation can learn from this error to prevent similar errors in the future

A medication error/incident may be a source of concern and stress for employees, and it is the line manager’s responsibility to ensure that the staff wellbeing are understood and where appropriate, supported. Line managers can refer employees to Occupational Health (OH) if an employee exhibits or has potential stress related ill health. Duties can be temporarily adjusted if required to support safety and confidence The contact details for OH: Telephone: 0345 643 3468 Email: ang-sa.Occupationalhealth@nhs.net The Human Resources (HR) department is responsible for leading on all matters relating to the employees of Provide and can help employees resolve any queries and issues they have during their employment. HR focuses on ways to help all employees to perform to the best of their abilities. Refer to Psychological Wellbeing of Staff Policy and Procedure (HRPOL26) for information about addressing concerns regarding work related stress or psychological well-being. Appendix 4 sets out guidance on how to minimise errors from occurring. This highlights some of the problems which may occur in a community setting and identifies solutions on how to reduce the errors.

6. Medication Errors/Near Misses It is important that all members of staff and their managers comply fully with this guidance, to ensure the organisation is able to manage medication errors and near misses appropriately and particularly to ensure members of staff who make repeat errors/near misses are identified as soon as possible. By following the Algorithm in Appendix 1, line managers should seek to establish if this is a repeat error or near miss that has occurred within the preceding 3 months. Managers should review patterns of incidents to understand contributory factors such as workload, environment, supervision, or system design. Capability or disciplinary processes should only be considered where: • Unsafe practice persists despite support and training • There is evidence of gross negligence, deliberate acts or wilful disregard of procedures This reflects a Being Fair Culture approach focused on learning and improvement.

7. Role of the Pharmacy Team Medication incidents that are reported via Datix will be reviewed by the Medication Safety Officer to identify learning, trends and opportunities for improvement. Any incidences relating to Controlled Drugs will be reviewed by the Accountable Officer, Nisha Desai, Director Quality, Pharmacy and AHP. The purpose of this review is essentially twofold:

Page 9 of 16


• • • •

To establish if appropriate medicines management policies and procedures are in place to support staff in their practice To support the process of learning lessons and sharing these lessons with key staff following any medication incident, via the Medicines Governance & Safety Group To ensure Provide processes are reviewed by the relevant department To determine where Controlled Drug (CD) incidents have been reported need reporting to the Police

(Please refer to QPOL01: All Incident Reporting (including Serious Incident Reporting) & Management Policy for further details on reporting requirements).

8. Training and Competencies Training needs should be identified through: • • • •

Local reviews Swarm huddles After Action Reviews PSIR / SII where applicable

The Learning and Development unit should be used to register for any Medicines Management related training needs identified.

Page 10 of 16


Appendix 1: Algorithm for the Management of Medication Errors/Near Misses Assess Error / Near Miss Assess Patient Seek Specialist Advice- 111, Community Pharmacy 999 Follow Appendix 2 if appropriate

Low / Medium Severity (yellow risk) (No harm to patient/minor harm)

• • • •

Inform Senior Manager Report incident on Datix Duty of Candour Support staff involved

•

Ask staff involved to reflect on incident and include comments on the Datix Form Follow up patient condition

•

•

Arrange discussion between member of staff and Line Manager / Senior Nurse dependant on the outcome of the incident Supportive discussion to include reflection by member/s of staff Establish if this is a repeat error/near miss by member/s of staff – is re-training required?

• •

Significant Severity (Orange risk) (Moderate Harm)

• • • • •

• • •

1.

•

•

•

Refer for Medicines Management Training & Support If first occurrence, offer additional support and supervised administration to re-assess competencies If repeat occurrence within the last 3 months, suspension from medicines administration until competencies re-assessed If repeat occurrence, confirm the first error’s actions are completed

Inform Senior Manager Report Incident on Datix Duty of Candour Support staff involved Incident managed in line with Incident Reporting Policy

Member/s of staff involved to complete reflective account, include comments on the Datix Form Follow up patient condition Additional Learning through Swarm huddle/ After Action Review, Review at Incident Review Panel

If this is a first medication error/near miss: • Arrange medication training • Arrange supportive discussion with member/s of staff and manager and to explain process for review that is to be followed • Supervised practice only for 10 occasions, or as appropriate to service If this is a repeat medication error/near miss within the preceding 3month period: • Suspend member/s of staff from medication process • Arrange medication training • Arrange supportive discussion with member/s of staff and manager and to explain the process for review that is to be followed

2.

Actions: •

High Severity (Red risk) (Severe harm/death)

Actions: • • • • • • •

Suspension from medicines administration if a serious incident has occurred from Time Critical Medicines Consideration of initiating the Capability / Disciplinary Procedure if formal investigation is required Training is completed before lifting suspension period A period of supervision is arranged after suspension has been lifted (3 months) Check equipment is not faulty Check individual competencies If any further doubt in competency, raise with Senior Management

Page 11 of 16


Appendix 2: Managing a Medication Error/Near Miss – Things to Consider Are there immediate/potential risks to the patient/service user/customer from the incident?

Does the patient/service user/customer require immediate medical intervention? If so, seek help immediately ringing 999

If a drug error has occurred, consider the potential for serious harm and if a reversible should be administered? Ask for an urgent medical review.

Have immediate necessary observations been completed e.g. Pulse, BP, Blood Glucose, consider any on-going patient/service user/customer observations if appropriate

Has the doctor responsible for the patient/service user/customer’s care been informed with medical review requested? Urgency dependent upon seriousness of incident.

Has someone agreed the appropriate time to inform the patient/service user/customer/carers of the nature of the incident?

Has the senior nurse / senior manager / registered manager been informed and has appropriate support been offered to the healthcare personnel involved in the incident?

Have you identified who will report the incident on Datix – this must be as soon as practicably possible but within 48 hours. For Sch2 and 3 CD the AO needs to be contacted within 24 hours and a Datix MUST be raised within 48 hours. For missing Sch2 and 3 CD a crime reference number is needed for the Datix (from the Police). Accountable Officer: Nisha Desai 07580911601

Has the incident been documented in the patient/service user/customer record?

Has the incident been risk assessed and lessons for learning been identified?

Page 12 of 16


Appendix 3: Clinical Incidents Related to Medicines Introduction Relevant to all Provide staff in procurement, prescribing, administration, dispensing and handling medicines within Provide.

Purpose To define the Provide procedure for clinical incidents related to medicines, and to provide a resource to direct clinicians to other relevant policies, procedures and guidelines. Refer to: • MMPOL30 Medicines Management Policy • MMGUI60 Managing and Supporting Staff following a Medication Error • Professional body standards for prescribers and non-medical prescribers (NMPs)

Religion, Equality, Human Rights and Promoting Dignity and Respect Clinicians must ensure they consider religious observances, equality, human rights and the promotion of dignity and respect in relation to prescribing, administering and handling medicines. The principles of informed consent and the Mental Capacity Act should be followed.

Process to Follow Clinicians involved in identifying clinical incidents related to medicines should be mindful of their professional obligations related to patient/service user/customer safety. In any clinical incident related to medicines, patient/service user/customer safety is paramount, and reasonable steps should always be taken to minimise any immediate risk to patient/service user/customers. Reasonable steps include: • Isolating stocks of medicines that are defective or may display evidence of tampering • Seeking medical advice as soon as possible • Involving senior staff as soon as possible • Considering the appropriate cause of action in relation to the member of staff involved, depending upon the severity of the incident and whether this is an isolated incident or if the member of staff has been involved in other medicines incidents in the last 3 months • Suspending a member of staff from administration duties, if necessary, after assessment • Contacting a patient/service user/customer promptly in relation to an identified dispensing or administration error • Contacting the Medicines Management team where appropriate, to aid in the incident • Raising a Datix • Informing the Accountable Officer for Controlled Drugs Schedule 2 and 3 • Raising as a Patient/service user/customer Safety Incident (PSI) if appropriate Where foul play is suspected, the member of staff should be suspended and the police contacted. Internal security is essential to instigate an investigation as soon as possible. Senior staff should be contacted immediately to aid in the decision-making process.

Page 13 of 16


All medication incidents and near misses must be reported via Datix within 48 hours of the incident occurring. Any incidents thought to be of a serious nature must be reported immediately.

Adverse Drug Reactions Suspected adverse reactions to drugs are notifiable by doctors, nurses, patient/service user/customers and pharmacists through the Yellow Cards Scheme. Advice and Yellow Cards are available from the MHRA Website and are included in the British National Formulary (BNF). For the reporting of suspected adverse drug reactions, refer to the Yellow Card Scheme. See current British National Formulary (BNF) or via www.mhra.gov.uk

Controlled Drugs The Accountable Officer must be provided with information regarding any complaints, incidents or concerns in relation to controlled drug within 24 hours of the incident being identified. Controlled drugs issues relating to independent contractors (e.g. General Practitioners and Community Pharmacy) will be forwarded to the respective CCG and NHS England. Refer to MMPOL31 Controlled Drugs Policy, MMSOP41 Controlled Drugs Suite of SOPs and MMSOP63 Safe use of Gabapentin and Pregabalin in Community Inpatient/service user/customer Wards.

Contact Details for Poisons and Drug Overdoses UK National Poisons Information Service (NPIS) – Telephone 0344 892 0111, https://www.toxbase.org/

Monitoring and Compliance Compliance will be monitored continuously via the Datix incident reporting system and will be reviewed bi-monthly at the Medicines Governance & Safety Group (MGSG) meetings.

Page 14 of 16


Appendix 4: Stages of Medication Processes STAGES OF MEDICATION PROCESSES PROBLEMS • • •

Overlooking drug allergies Major Drug Interactions Suboptimal medication choices based on clinical indication, Comorbid conditions, existing medication

SOLUTIONS

PRESCRIBING

• •

Access to drug information Computerised Alerts and Decision Support

•

Write both brand and generic; where needed write indication Do not use trailing zeros (1 mg NOT 1.0 mg) but do use leading zeros (0.1 NOT .1) Avoid abbreviations – micrograms NOT mcg or ug units NOT U or IU (this can look like a 0)

• • • •

•

Drug substitution due to similar name e.g. Cerebyx and Celebrex Missed decimal point on lined paper, carbon copies or faxed copies Ambiguous or hastily written abbreviations for frequency, units or route of administration

System and Human Errors internal to the pharmacy, which can be impacted by: Look alike sound alike drugs, similar packaging can result in drug substitution

TRANSCRIBING

•

•

DISPENSING

•

• •

• • • •

Incorrect dosage administered Not all tablets given to patient/service user/customer Patient/service user/customer not wanting to take Patient self-administering

ADMINISTERING

• • • •

• • •

Electrolyte disturbances Decreased Renal function Prolonged over or under anticoagulation

MONITORING

Page 15 of 16

•

Use of caution stickers if similar medication is kept together Keep possibility of dispensing errors in mind

Clearly explain to patient/service user/customer what the intended medication is for in simple terms Periodically review what and when patient/service user/customers are taking Clearly check documentation of what is to be administered (highlight AM dose and PM dose in different markers Check blister pack slot is empty or use a Pil-Bob to administer Tabards to be worn on in-patient/service user/customer ward when carrying out medication round Staff not to be disturbed during medication round

Checklist reminders for high-risk drugs especially in the elderly and those medicines which are weight or creatine level dependent


Appendix 5: Being Fair Tool Please refer to: https://www.england.nhs.uk/patient/service safety/patient/service user/customer-safety-culture/being-fair-tool/

Page 16 of 16

user/customer-


Turn static files into dynamic content formats.

Create a flipbook